137 related articles for article (PubMed ID: 6205577)
1. Evaluation of the effects of catheter sampling for the study of platelet behavior in the pulmonary and coronary circulation.
Bugiardini R; Chierchia S; Crea F; Gallino A; Wild S; Roskovec A; Lenzi S; Maseri A
Am Heart J; 1984 Aug; 108(2):255-60. PubMed ID: 6205577
[TBL] [Abstract][Full Text] [Related]
2. Serial determinations of PF4 and beta TG: comparisons between multiple venipunctures vs a catheter infusion system.
Strauss W; Cella G; Myers C; Sasahara AA
Thromb Haemost; 1988 Jun; 59(3):491-4. PubMed ID: 2973152
[TBL] [Abstract][Full Text] [Related]
3. Differential transmyocardial platelet behavior in response to pacing and ergonovine-induced myocardial ischemia.
Bugiardini R; Chierchia S; Davies G; Crea F; Lenzi S; Maseri A
Am Heart J; 1986 Aug; 112(2):255-62. PubMed ID: 2943147
[TBL] [Abstract][Full Text] [Related]
4. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
5. Serial studies of platelet factor 4 and beta thromboglobulin during exercise in patients with coronary artery disease.
Strauss WE; Cella G; Parisi AF; Sasahara AA
Am Heart J; 1985 Aug; 110(2):293-9. PubMed ID: 2411121
[TBL] [Abstract][Full Text] [Related]
6. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia.
Atalar E; Haznedaroglu IC; Acil T; Ozer N; Kilic H; Ovunc K; Aksoyek S; Nazli N; Kes S; Kabakçi G; Kirazli S; Ozmen F
Platelets; 2003; 14(7-8):407-11. PubMed ID: 14713509
[TBL] [Abstract][Full Text] [Related]
7. Transcoronary platelet activation and consumption in coronary artery disease: studies at rest.
Mant MJ; Kappagoda CT; Taylor RF; Quinlan JE
Thromb Res; 1988 Apr; 50(1):201-11. PubMed ID: 2969633
[TBL] [Abstract][Full Text] [Related]
8. Heparin-releasable platelet factor 4 in patients with coronary artery disease.
Sadayasu T; Nakashima Y; Yashiro A; Kawashima T; Kuroiwa A
Clin Cardiol; 1991 Sep; 14(9):725-9. PubMed ID: 1835913
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation caused by cardiac catheter blood collection, and its prevention.
Mant MJ; Kappagoda CT; Taylor RF; Quinlan JE
Thromb Res; 1984 Jan; 33(2):177-87. PubMed ID: 6230755
[TBL] [Abstract][Full Text] [Related]
10. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of platelet-specific proteins in young female acute myocardial infarction survivors and their age-matched female controls.
Kutti J; Johansson S; Eriksson KA; Sigvaldason A; Vedin A; Wadenvik H; Wilhelmsson C
Eur Heart J; 1983 May; 4(5):300-5. PubMed ID: 6193960
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of plbatelet-specific proteins in coronary artery disease.
Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaindl F
Cardiology; 1981; 68(3):129-38. PubMed ID: 6172197
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation in response to phlebotomy. An experimental study of healthy blood donors.
Eriksson KA; Sigvaldason A; Lindholm A; Safai-Kutti S; Kutti J
Acta Med Scand; 1982; 212(3):121-3. PubMed ID: 6183925
[TBL] [Abstract][Full Text] [Related]
14. Plasma beta-thromboglobulin and platelet factor 4 in patients with chronic renal failure and effect of hemodialysis.
Endo Y; Mamiya S; Satoh M; Takahashi K; Harada T
Tohoku J Exp Med; 1981 Dec; 135(4):349-58. PubMed ID: 6175048
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
[TBL] [Abstract][Full Text] [Related]
16. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
Rosove MH; Frank HJ; Harwig SS
Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
[TBL] [Abstract][Full Text] [Related]
17. The effect of anticoagulant mixtures on BTG and PF4 levels.
Randi ML; Fabris F; Casonato A; Girolami A
Thromb Haemost; 1981 Aug; 46(2):569. PubMed ID: 6171043
[No Abstract] [Full Text] [Related]
18. Platelet activation and fibrinopeptide formation in pulmonary hypertension.
Schulman LL; Grossman BA; Owen J
Chest; 1993 Dec; 104(6):1690-3. PubMed ID: 8252943
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
Ferri GM; Afeltra A; Caccavo D; Amoroso A
Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709
[No Abstract] [Full Text] [Related]
20. Platelet alpha granule release in diabetes mellitus.
Sacchi S; Curci G; Piccinini L; Cucci F; Messerotti A; Roncaia R; Benedetti PG
Scand J Clin Lab Invest; 1985 Apr; 45(2):165-8. PubMed ID: 2408317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
